COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 octobre 2025
Déclaration du nombre total de droits de vote et d'actions de L'Oréal au 31 octobre 2025 conformément aux réglementations en vigueur, ainsi que des informations sur l'entreprise et ses activités -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
Heidelberg Pharma AG announces changes to the Executive Management Board - Dr. Dongzhou Jeffery Liu appointed as Chairman of the Executive Board and Chief Executive Officer -
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones
Jaguar Health, Inc. secures new patent expanding international IP for crofelemer in pediatric intestinal failure disorders, highlighting reductions in parenteral support. Supporting business development plans
